Net sales grew 1.7% year-over-year, driven by the Products segment, while adjusted EBITDA remained stable. Kronans Apotek showed improved profitability, and the outlook anticipates further EBITDA growth in 2026 despite ongoing geopolitical and cost pressures.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.